Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N V COM | 4,289,304 | 4,639,304 | +350,000 | $75.49M | $115.75M | 65.62% | +$40.26M |
| Alumis Inc | 4,619,803 | 4,619,803 | 0 | $13.86M | $18.43M | 10.45% | +$4.57M |
| ALX Oncology Holdings Inc.(ALXO) | 9,699,925 | 9,699,925 | 0 | $4.03M | $17.75M | 10.06% | +$13.72M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 489,194 | 489,194 | 0 | $15.46M | $13.48M | 7.64% | -$1.98M |
| Lyell Immunopharma, Inc.(LYEL) | 473,479 | 473,479 | 0 | $4.19M | $7.69M | 4.36% | +$3.50M |
| Artiva Biotherapeutics, Inc.(ARTV) | 1,148,975 | 1,148,975 | 0 | $1.73M | $3.30M | 1.87% | +$1.56M |